ArticleInternational journal of rheumatic diseases2021

What are the benefits and harms of belimumab for patients with systemic lupus erythematosus?: A Cochrane Review summary with commentary.

Giovanni IolasconPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.